pI: 6.5051 |
Length (AA): 482 |
MW (Da): 54515 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128950)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G13860 | ELC-like protein |
Arabidopsis thaliana | AT3G12400 | protein ELC |
Brugia malayi | Bm1_08825 | hypothetical protein |
Candida albicans | CaO19.2343 | weak similarity to S. cerevisiae STP22 putative ubiquitin receptor, and to mouse tumor susceiptibility protein TSG101 |
Candida albicans | CaO19.9879 | weak similarity to S. cerevisiae STP22 putative ubiquitin receptor, and to mouse tumor susceiptibility protein TSG101 |
Caenorhabditis elegans | CELE_C09G12.9 | Protein TSG-101 |
Dictyostelium discoideum | DDB_G0286797 | tumor susceptibility gene 101 protein |
Drosophila melanogaster | Dmel_CG9712 | Tumor susceptibility gene 101 ortholog (H. sapiens) |
Echinococcus granulosus | EgrG_000664100 | tumor susceptibility gene 101 protein |
Entamoeba histolytica | EHI_178530 | tumor susceptibility gene 101 protein, putative |
Echinococcus multilocularis | EmuJ_000664100 | tumor susceptibility gene 101 protein |
Homo sapiens | ENSG00000074319 | tumor susceptibility 101 |
Loa Loa (eye worm) | LOAG_08265 | hypothetical protein |
Mus musculus | ENSMUSG00000014402 | tumor susceptibility gene 101 |
Oryza sativa | 4331267 | Os02g0833300 |
Saccharomyces cerevisiae | YCL008C | ubiquitin-binding ESCRT-I subunit protein STP22 |
Schistosoma japonicum | Sjp_0313380 | Conserved hypothetical protein |
Schistosoma japonicum | Sjp_0021440 | ko:K01931 tumor suppressor protein 101 [EC:6.3.2.19], putative |
Schistosoma japonicum | Sjp_0014070 | Tumor susceptibility gene 101 protein, putative |
Schistosoma mansoni | Smp_193270 | tsg101-related |
Schistosoma mansoni | Smp_182310 | tsg101-related |
Schistosoma mansoni | Smp_193790 | tsg101-related |
Schmidtea mediterranea | mk4.009690.00 | Tumor susceptibility gene 101 protein |
Schmidtea mediterranea | mk4.000151.06 | Tumor susceptibility gene 101 protein |
Schmidtea mediterranea | mk4.000151.07 | |
Schmidtea mediterranea | mk4.008006.00 | Tumor susceptibility gene 101 protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_C09G12.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C09G12.9 | Caenorhabditis elegans | larval lethal | wormbase |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | tumor susceptibility 101 | Compounds | References |